284 related articles for article (PubMed ID: 34452370)
21. FCV-VBS isolated from cats with typical symptoms caused VSD in experimental cats.
Ohe K; Takahashi T; Hara D; Hara M
Vet Res Commun; 2008 Feb; 32(2):145-58. PubMed ID: 17899424
[TBL] [Abstract][Full Text] [Related]
22. DNA vaccination against feline calicivirus infection using a plasmid encoding the mature capsid protein.
Sommerville LM; Radford AD; Glenn M; Dawson S; Gaskell CJ; Kelly DF; Cripps PJ; Porter CJ; Gaskell RM
Vaccine; 2002 Mar; 20(13-14):1787-96. PubMed ID: 11906766
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of intranasal administration of a modified live feline herpesvirus 1 and feline calicivirus vaccine against disease caused by Bordetella bronchiseptica after experimental challenge.
Bradley A; Kinyon J; Frana T; Bolte D; Hyatt DR; Lappin MR
J Vet Intern Med; 2012; 26(5):1121-5. PubMed ID: 22860699
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a feline viral rhinotracheitis-feline calicivirus disease vaccine.
Scott FW
Am J Vet Res; 1977 Feb; 38(2):229-34. PubMed ID: 190925
[TBL] [Abstract][Full Text] [Related]
25. Antibody Response to Feline Calicivirus Vaccination in Healthy Adult Cats.
Bergmann M; Speck S; Rieger A; Truyen U; Hartmann K
Viruses; 2019 Jul; 11(8):. PubMed ID: 31370359
[TBL] [Abstract][Full Text] [Related]
26. Neutralizing feature of commercially available feline calicivirus (FCV) vaccine immune sera against FCV field isolates.
Hohdatsu T; Sato K; Tajima T; Koyama H
J Vet Med Sci; 1999 Mar; 61(3):299-301. PubMed ID: 10331208
[TBL] [Abstract][Full Text] [Related]
27. Environmental Contamination and Hygienic Measures After Feline Calicivirus Field Strain Infections of Cats in a Research Facility.
Spiri AM; Meli ML; Riond B; Herbert I; Hosie MJ; Hofmann-Lehmann R
Viruses; 2019 Oct; 11(10):. PubMed ID: 31627345
[TBL] [Abstract][Full Text] [Related]
28. Results of molecular diagnostic assays targeting feline herpesvirus-1 and feline calicivirus in adult cats administered modified live vaccines.
Ruch-Gallie RA; Veir JK; Hawley JR; Lappin MR
J Feline Med Surg; 2011 Aug; 13(8):541-5. PubMed ID: 21439879
[TBL] [Abstract][Full Text] [Related]
29. Feline calicivirus and other respiratory pathogens in cats with Feline calicivirus-related symptoms and in clinically healthy cats in Switzerland.
Berger A; Willi B; Meli ML; Boretti FS; Hartnack S; Dreyfus A; Lutz H; Hofmann-Lehmann R
BMC Vet Res; 2015 Nov; 11():282. PubMed ID: 26566897
[TBL] [Abstract][Full Text] [Related]
30. Feline calicivirus.
Radford AD; Coyne KP; Dawson S; Porter CJ; Gaskell RM
Vet Res; 2007; 38(2):319-35. PubMed ID: 17296159
[TBL] [Abstract][Full Text] [Related]
31. A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens.
Dawson S; Willoughby K; Gaskell RM; Wood G; Chalmers WS
J Feline Med Surg; 2001 Mar; 3(1):17-22. PubMed ID: 11716626
[TBL] [Abstract][Full Text] [Related]
32. Effect of modified live or inactivated feline herpesvirus-1 parenteral vaccines on clinical and laboratory findings following viral challenge.
Summers SC; Ruch-Gallie R; Hawley JR; Lappin MR
J Feline Med Surg; 2017 Aug; 19(8):824-830. PubMed ID: 27432436
[TBL] [Abstract][Full Text] [Related]
33. An outbreak of virulent systemic feline calicivirus disease.
Hurley KE; Pesavento PA; Pedersen NC; Poland AM; Wilson E; Foley JE
J Am Vet Med Assoc; 2004 Jan; 224(2):241-9. PubMed ID: 14736069
[TBL] [Abstract][Full Text] [Related]
34. The challenge for the next generation of feline calicivirus vaccines.
Radford AD; Dawson S; Coyne KP; Porter CJ; Gaskell RM
Vet Microbiol; 2006 Oct; 117(1):14-8. PubMed ID: 16698199
[TBL] [Abstract][Full Text] [Related]
35. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens.
Kanellos T; Sutton DJ; Salisbury CF; Chalmers WS
J Feline Med Surg; 2008 Aug; 10(4):346-54. PubMed ID: 18448375
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of an inactivated feline calicivirus (FCV) vaccine against challenge with United Kingdom field strains and its interaction with the FCV carrier state.
Gaskell CJ; Gaskell RM; Dennis PE; Wooldridge MJ
Res Vet Sci; 1982 Jan; 32(1):23-6. PubMed ID: 6283611
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of a bivalent inactivated non-adjuvanted feline calicivirus vaccine: relation between in vitro cross-neutralization and heterologous protection in vivo.
Poulet H; Jas D; Lemeter C; Coupier C; Brunet S
Vaccine; 2008 Jul; 26(29-30):3647-54. PubMed ID: 18541348
[TBL] [Abstract][Full Text] [Related]
38. An Update on Feline Calicivirus.
Spiri AM
Schweiz Arch Tierheilkd; 2022 Mar; 164(3):225-241. PubMed ID: 35232714
[TBL] [Abstract][Full Text] [Related]
39. Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines.
Lappin MR; Veir J; Hawley J
J Feline Med Surg; 2009 Feb; 11(2):159-62. PubMed ID: 18782676
[TBL] [Abstract][Full Text] [Related]
40. Ability of vaccine strain induced antibodies to neutralize field isolates of caliciviruses from Swedish cats.
Wensman JJ; Samman A; Lindhe A; Thibault JC; Berndtsson LT; Hosie MJ
Acta Vet Scand; 2015 Dec; 57():86. PubMed ID: 26655039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
